About
Technology
Issues
FAQ
Links
Official Page
An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.